mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |